BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 2454265)

  • 1. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.
    Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA
    J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.
    Coeshott CM; Chesnut RW; Kubo RT; Grammer SF; Jenis DM; Grey HM
    J Immunol; 1986 Apr; 136(8):2832-8. PubMed ID: 2420871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of antigen-specific and MHC-restricted B cell hybridoma clones: a model for studying antigen presentation to T cell lines and clones.
    Zimecki M; Kapp JA; Pierce CW
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):395-408. PubMed ID: 2471476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines.
    Altman A; Sferruzza A; Weiner RG; Katz DH
    J Immunol; 1982 Mar; 128(3):1365-71. PubMed ID: 6120196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
    Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.
    Kim KH; Thomas DW
    J Immunol; 1988 Apr; 140(8):2500-7. PubMed ID: 3258611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
    Del Pozo V; De Andrés B; Martín E; Cárdaba B; Fernández JC; Gallardo S; Tramón P; Leyva-Cobian F; Palomino P; Lahoz C
    Eur J Immunol; 1992 Jul; 22(7):1919-25. PubMed ID: 1623930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of cloned macrophage hybridomas. VI. Differential ability to induce immunity or suppression.
    Kuchroo VK; Minami M; Diamond B; Dorf ME
    J Immunol; 1988 Jul; 141(1):10-6. PubMed ID: 2454255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation.
    Glimcher LH; Schroer JA; Chan C; Shevach EM
    J Immunol; 1983 Dec; 131(6):2868-74. PubMed ID: 6196405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IL 2-secreting T cell hybridoma that responds to a self class I histocompatibility antigen in the H-2D region.
    Endres RO; Marrack P; Kappler JW
    J Immunol; 1983 Oct; 131(4):1656-62. PubMed ID: 6604749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance.
    Berkower I; Kawamura H; Matis LA; Berzofsky JA
    J Immunol; 1985 Oct; 135(4):2628-34. PubMed ID: 2411806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of cultured Langerhans cells to process and present protein antigens is MHC-dependent.
    Aiba S; Katz SI
    J Immunol; 1991 Apr; 146(8):2479-87. PubMed ID: 1849934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants.
    Webb SR; Okamoto A; Sprent J
    J Immunol; 1988 Sep; 141(6):1828-34. PubMed ID: 2459192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of IL 1 in the antigen-specific activation of murine class II-restricted T lymphocyte clones.
    McKean DJ; Nilson A; Beck BN; Giri J; Mizel SB; Handwerger BS
    J Immunol; 1985 Nov; 135(5):3205-16. PubMed ID: 2413115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
    Iwata M; Katamura K; Kubo RT; Ishizaka K
    J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.